StockData
Danaher Corp logo

Danaher Corp

DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3027% above fair value
$232.23−4.75 (-2.00%)

Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –

Danaher Radiometer Medical by Year

Radiometer Medical — Clinical Trials Started During the Year (cumulative total of 19 studies)

Danaher Radiometer Medical: 6 in FY2025, up 200.0% from a year earlier. That is the highest of the 9 years on record here.

Latest, FY2025
6
Period ended Dec 31, 2025
Change on a year earlier
+200.0%
2 in FY2024
History
9 years
Since FY2016
Sources
1
NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry)

Where the FY2025 figure comes from

Source: NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗

Reported in NIH ClinicalTrials.gov API v2.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Danaher Radiometer Medical, annual FY2016–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/ext-ct-studies-radiometer

See every metric in the Danaher KPI table. Data updated Nov 2, 2026.